Recent Events & Catalysts
Dyne Therapeutics, Inc. (DYN) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Morgan Stanley Maintains Overweight on Dyne Therapeutics, Lowers Price Target to $45
Benzinga · 11d ago
RBC Capital Maintains Outperform on Dyne Therapeutics, Raises Price Target to $35
Benzinga · 12d ago
Dyne Therapeutics Q2 EPS $(1.08) Misses $(0.75) Estimate
Benzinga · 13d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-07-29 · 13d ago · Material
Entry into a material agreement, Other events, Financial statements and exhibits
Filed 2026-07-22 · 20d ago
Other events
Filed 2026-07-20 · 22d ago
Departure/appointment of directors or officers
Filed 2026-06-22 · 50d ago
Entry into a material agreement, Creation of a direct financial obligation (new debt)
Filed 2026-06-17 · 55d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.